CD79A and agammaglobulinemia: Moreover, we suggested to validate the IgA anti-PnPS23 in other primary immune deficiency such as Selective Antibody Deficiency where the diagnosis is hindered by a lack of controlled clinical studies and the absence of a standardized definition of an insufficient pneumococcal polysaccharide antibody response (26).